Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study for Combination of Camrelizumab and SBRT in the First-line Treatment for R/M HNSCC
- Status
- UNKNOWN
- Phase
- PHASE2
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer
- Status
- RECRUITING
- Phase
- PHASE2
HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure
- Status
- COMPLETED
- Phase
- PHASE2
Epigenetic Changes in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- N/A
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Feasibility of a Carbohydrate-restricted, High-fat Diet on Head and Neck Squamous Cell Carcinoma Outcomes
- Status
- COMPLETED
- Phase
- NA
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Ribociclib and Spartalizumab in R/M HNSCC
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)
- Status
- COMPLETED
- Phase
- PHASE3